Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Quarterly call transcripts

<< Previous

Bullboard Posts

Next >>

Post by mdjbrownon Jun 19, 2024 12:11pm

125 Views

Post# 36096100

Quarterly call transcripts

If you have time to go back and read the quarterly call transcripts back to 2020, there is a lot of good info directly from the execs.

Q2, 2023
‘If and when our pharmaceutical partner is successful in their generic application to produce a generic Epidiolex and distribute it’……………………

Q3, 2023
“There are many other great commercial projects happening at MediPharm, including preparing for a CBD natural health product channel in Canada, preparing for future generic Epidiolex in the U.S. and growing our clinical study business.”

https://www.alphaspread.com/security/tsx/labs/earnings-calls/q4-2023

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages